ReachMDNew 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery

A Weill Cornell Medicine pilot study of AI-driven 3D MRI technology eliminated residual fibroids in complex myomectomy cases, while surgeons without it had detectable remnants at 6-month follow-up. The stakes are significant: 30% to 40% of fibroid surgery patients return for additional procedures within 5 years, often due to incomplete initial removal. The technology converts standard 2D MRIs into rotatable 3D surgical maps integrated directly with robotic platforms.

Clinical Considerations

• Residual fibroids after myomectomy drive the majority of reoperation burden; comprehensive first-pass removal directly reduces this risk
• 3D MRI mapping visualizes fibroid location relative to bladder, vasculature, and ovarian blood supply, reducing intraoperative anatomical uncertainty
• Pilot cohort involved complex, multi-fibroid cases, suggesting benefit is greatest where standard imaging falls short
• Technology remains investigational; broader availability and prospective trial data are needed before standard-of-care adoption

Practice Applications

• Counsel fibroid patients that surgical completeness, not just technique, drives long-term symptom outcomes and reoperation risk
• Monitor emerging 3D MRI and AI imaging tools for integration into your institution’s surgical planning workflow
• Document preoperative imaging limitations when counseling patients on myomectomy recurrence risk and reoperation probability
• Refer complex multi-fibroid cases to high-volume centers with advanced imaging capabilities when available

More in Reproductive Endocrinology